UNIVERSITY OF STRATHCLYDE, GLASGOW, UNITED KINGDOM. HemoSep is a device that aids in the reduction of the needed transfusion on post-surgeries. In open-heart surgeries, the blood is sucked from the surgical site or from another machine used in the surgery. A chemical sponge and a mechanical agitator in the blood bag of the device are used to concentrate the spilled blood.
One of the main concerns in the medical field is known as MBL or Massive Blood Loss. It is one of the leading causes of death during cardiac surgeries. The process of blood transfusion may be helpful but it has its share of complications. This prompted to the development of a new device that can collect the blood from a patient, concentrates the blood cells and routes it intravenously right back to the patient being operated.
The developers from the University of Strathclyde has been successful in lowering the amount of blood needed from a donor and a possible bad reaction in blood transfusions. HemoSep is a simpler process since it does not require any trained professional that will draw blood from another person. Any bad reactions are absolutely avoided since the device utilizes the patient’s own blood.
The autotransfusion process has definitely eradicated the need for a complex centrifuge and pumping apparatus. It has been clinically tested during open-heart surgery procedures at Kirikkale University Hospital in Turkey and had a 100% success rate. The target launch of HemoSep for commercial use will be next month.
| Invention | HemoSep |
|---|---|
| Organization | University of Strathclyde, Glasgow, United Kingdom |
| Researcher | Terry Gourlay & Team |
| Field(s) | Blood Transfusion, Autotransfusion, Biomedical Engineering, Open-Heart Surgery, Neurosurgery, Organ Transplant, Orthopedic |
| Further Information | POPSCI |
